Ipilimumab and Pembrolizumab Mixed Response in a 41-Year-Old Patient with SMARCA4-Deficient Thoracic Sarcoma: An Interdisciplinary Case Study

SMARCA4-deficient thoracic sarcoma is a newly described entity of thoracic sarcomas with a poor prognosis, defined by poorly differentiated epithelioid to rhabdoid histomorphology and SMARCA4 gene inactivation. We present a case of a SMARCA4-deficient thoracic sarcoma in a 41-year-old male with a sm...

Descripción completa

Detalles Bibliográficos
Autores principales: Anžič, Nina, Krasniqi, Fatime, Eberhardt, Anna-Lena, Tzankov, Alexandar, Haslbauer, Jasmin Dionne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215992/
https://www.ncbi.nlm.nih.gov/pubmed/34177520
http://dx.doi.org/10.1159/000515416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215992/
https://www.ncbi.nlm.nih.gov/pubmed/34177520
http://dx.doi.org/10.1159/000515416

Ejemplares similares